FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
Read More
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
FDA
FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats
The FDA authorized emergency use of Capstar and generic Nitenpyram to prevent and treat New World screwworm in dogs and cats nationwide.
Read More
FDA approves first drug to treat Alexander disease, offering a targeted therapy for the ultra-rare, progressive neurodegenerative disorder in children
The FDA approved Zanvastro, the first drug to treat Alexander disease by targeting abnormal GFAP buildup in pediatric and adult patients.
Read More
FDA Approves Roivant’s Lisraya (brepocitinib) as First Oral Drug for Dermatomyositis
The FDA approved Roivant’s Lisraya (brepocitinib), the first oral dual TYK2/JAK1 inhibitor, to treat dermatomyositis in adults.
Read More
FDA Recalls 12 Herbal Supplements Over Hidden Drug Ingredients
GURU INC. recalled Infla-650 herbal supplement after FDA found undeclared drugs acetaminophen, diclofenac, and phenylbutazone in the capsules.
Read More
FDA approves brepocitinib, the first oral drug for dermatomyositis in adults
The FDA approved LISRAYA (brepocitinib), the first oral TYK2/JAK1 inhibitor for treating adult dermatomyositis, on August 27, 2026.
Read More
FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning
The FDA upgraded the recall of 1.6 million Midwest Poultry eggs to Class I due to a multistate Salmonella Enteritidis outbreak in 2026.
Read More
FDA approves new imaging agent for Alzheimer’s disease detection
The FDA approved Tauklarify, a tau PET imaging agent, for detecting tau pathology in adults evaluated for Alzheimer’s disease.
Read More
FDA approves Glenmark’s generic fluticasone propionate nasal spray
The FDA approved Glenmark’s generic Fluticasone Propionate Nasal Spray, equivalent to Flonase, for treating allergic rhinitis symptoms in the U.S.
Read MoreFDA expands Pluvicto approval to earlier-stage metastatic prostate cancer, nearly doubling eligible patients
The FDA approved Pluvicto with androgen receptor inhibitors for earlier-stage PSMA-positive metastatic hormone-sensitive prostate cancer, expanding patient eligibility.
Read More